Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075807462> ?p ?o ?g. }
- W2075807462 endingPage "1719" @default.
- W2075807462 startingPage "1707" @default.
- W2075807462 abstract "Neuroinflammation is a major risk factor in Parkinson's disease (PD). Alternative approaches are needed to treat inflammation, as anti-inflammatory drugs such as NSAIDs that inhibit cyclooxygenase-2 (COX-2) can produce devastating side effects, including heart attack and stroke. New therapeutic strategies that target factors downstream of COX-2, such as prostaglandin J2 (PGJ2), hold tremendous promise because they will not alter the homeostatic balance offered by COX-2 derived prostanoids. In the current studies, we report that repeated microinfusion of PGJ2 into the substantia nigra of non-transgenic mice, induces three stages of pathology that mimic the slow-onset cellular and behavioral pathology of PD: mild (one injection) when only motor deficits are detectable, intermediate (two injections) when neuronal and motor deficits as well as microglia activation are detectable, and severe (four injections) when dopaminergic neuronal loss is massive accompanied by microglia activation and motor deficits. Microglia activation was evaluated in vivo by positron emission tomography (PET) with [11C](R)PK11195 to provide a regional estimation of brain inflammation. PACAP27 reduced dopaminergic neuronal loss and motor deficits induced by PGJ2, without preventing microglia activation. The latter could be problematic in that persistent microglia activation can exert long-term deleterious effects on neurons and behavior. In conclusion, this PGJ2-induced mouse model that mimics in part chronic inflammation, exhibits slow-onset PD-like pathology and is optimal for testing diagnostic tools such as PET, as well as therapies designed to target the integrated signaling across neurons and microglia, to fully benefit patients with PD." @default.
- W2075807462 created "2016-06-24" @default.
- W2075807462 creator A5002567720 @default.
- W2075807462 creator A5018435550 @default.
- W2075807462 creator A5020127308 @default.
- W2075807462 creator A5038415177 @default.
- W2075807462 creator A5091178644 @default.
- W2075807462 date "2014-09-01" @default.
- W2075807462 modified "2023-10-12" @default.
- W2075807462 title "PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2" @default.
- W2075807462 cites W1893732739 @default.
- W2075807462 cites W1966388129 @default.
- W2075807462 cites W1966412118 @default.
- W2075807462 cites W1966613919 @default.
- W2075807462 cites W1966628948 @default.
- W2075807462 cites W1966918485 @default.
- W2075807462 cites W1969778772 @default.
- W2075807462 cites W1972146241 @default.
- W2075807462 cites W1973872423 @default.
- W2075807462 cites W1975437597 @default.
- W2075807462 cites W1975774284 @default.
- W2075807462 cites W1976728837 @default.
- W2075807462 cites W1976749972 @default.
- W2075807462 cites W1980410293 @default.
- W2075807462 cites W1980908499 @default.
- W2075807462 cites W1987123448 @default.
- W2075807462 cites W1988298653 @default.
- W2075807462 cites W1988869948 @default.
- W2075807462 cites W1989348564 @default.
- W2075807462 cites W1989775722 @default.
- W2075807462 cites W1990065905 @default.
- W2075807462 cites W1990872391 @default.
- W2075807462 cites W1992279068 @default.
- W2075807462 cites W1996694544 @default.
- W2075807462 cites W1997848553 @default.
- W2075807462 cites W1999722943 @default.
- W2075807462 cites W2004701802 @default.
- W2075807462 cites W2008657735 @default.
- W2075807462 cites W2009805066 @default.
- W2075807462 cites W2010000553 @default.
- W2075807462 cites W2010873975 @default.
- W2075807462 cites W2016470397 @default.
- W2075807462 cites W2016676102 @default.
- W2075807462 cites W2017047552 @default.
- W2075807462 cites W2017831280 @default.
- W2075807462 cites W2018473639 @default.
- W2075807462 cites W2018869671 @default.
- W2075807462 cites W2020656090 @default.
- W2075807462 cites W2022206129 @default.
- W2075807462 cites W2038636807 @default.
- W2075807462 cites W2038930890 @default.
- W2075807462 cites W2042380065 @default.
- W2075807462 cites W2044224589 @default.
- W2075807462 cites W2044566850 @default.
- W2075807462 cites W2045673589 @default.
- W2075807462 cites W2045707010 @default.
- W2075807462 cites W2046892501 @default.
- W2075807462 cites W2048247930 @default.
- W2075807462 cites W2049703902 @default.
- W2075807462 cites W2050054515 @default.
- W2075807462 cites W2051981816 @default.
- W2075807462 cites W2052004580 @default.
- W2075807462 cites W2054421268 @default.
- W2075807462 cites W2056546282 @default.
- W2075807462 cites W2057233739 @default.
- W2075807462 cites W2057919063 @default.
- W2075807462 cites W2058077554 @default.
- W2075807462 cites W2060220993 @default.
- W2075807462 cites W2063364482 @default.
- W2075807462 cites W2064202144 @default.
- W2075807462 cites W2069706904 @default.
- W2075807462 cites W2069849992 @default.
- W2075807462 cites W2070977771 @default.
- W2075807462 cites W2079693092 @default.
- W2075807462 cites W2084089231 @default.
- W2075807462 cites W2090476662 @default.
- W2075807462 cites W2092462980 @default.
- W2075807462 cites W2092862627 @default.
- W2075807462 cites W2093748306 @default.
- W2075807462 cites W2094715296 @default.
- W2075807462 cites W2097791196 @default.
- W2075807462 cites W2099671309 @default.
- W2075807462 cites W2123068902 @default.
- W2075807462 cites W2127235616 @default.
- W2075807462 cites W2128328936 @default.
- W2075807462 cites W2140044845 @default.
- W2075807462 cites W2142389530 @default.
- W2075807462 cites W2144078756 @default.
- W2075807462 cites W2148020944 @default.
- W2075807462 cites W2149298826 @default.
- W2075807462 cites W2149309211 @default.
- W2075807462 cites W2149538964 @default.
- W2075807462 cites W2157151225 @default.
- W2075807462 cites W2157587576 @default.
- W2075807462 cites W2159575294 @default.
- W2075807462 cites W2160496147 @default.
- W2075807462 cites W2160634538 @default.
- W2075807462 cites W2163441473 @default.